[ABBV]

Mid 2026-10-02 00:27:24

AbbVie long-term data buoys Rinvoq for vitiligo

Mid 2026-09-30 19:15:17

AbbVie's ABBV-295 delivers up to 9.8% weight loss in Phase 1

Mid 2026-09-30 15:29:09

AbbVie reports positive phase 2 data for Zumilokibart in atopic dermatitis

Mid 2026-09-28 21:24:07

AbbVie’s JUVMO wins FDA approval for Parkinson’s disease

Mid 2026-09-22 15:34:58

AbbVie gains EU approval for Rinvoq to treat pediatric arthritis